Occasional reports have mentioned the prevalence of multiple sclerosis (MS) among Gypsies, and no studies have examined to date the prevalence of MS or human leukocyte antigen (HLA) genetics… (More)
BACKGROUND
Subjects with immediate reactions to penicillins and positive skin test responses may lose sensitivity if penicillin is avoided. The longer the interval between the reaction and the skin… (More)
The role of the key catalytic residues Glu134 and Glu138 in the retaining 1,3-1,4-beta-glucanase from Bacillus licheniformis is probed by a chemical rescue methodology based on enzyme activation of… (More)
Evidence for the effectiveness of immunosuppressive agents in MS is scanty. There are few good quality trials; most have methodological limitations, such as a small sample size and short duration.… (More)
BACKGROUND
Although not definitively proven, there is commonly accepted to be a latitudinal gradient in the distribution of multiple sclerosis (MS), which is more frequent in temperate zones. The… (More)
OBJECTIVE
To study the relationship between human leucocyte antigen (HLA) genotype and clinical response to interferon-beta (IFN-beta).
METHODS
We analysed the HLA class II genotypes of 96 multiple… (More)
The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant (BPO) is a useful tool for evaluating suspected penicillin allergic subjects. Although many different methods have… (More)
OBJECTIVE
To evaluate the efficacy and safety of IFNbeta-1a (Avonex, Biogen, Inc., Cambridge, MA, USA) in patients with relapsing-remitting multiple sclerosis (MS).
METHODS
In this multicenter,… (More)
BACKGROUND
Little is known about how the level of disability at the start of treatment with natalizumab affects its efficacy.
OBJECTIVES
The aim of this study was to investigate the effect of… (More)